Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies

BACKGROUND: Linezolid is increasingly important for multidrug-resistant tuberculosis (MDR-TB) treatment. However, among children with MDR-TB, there are no linezolid pharmacokinetic data, and its adverse effects have not yet been prospectively described. We characterised the pharmacokinetics, safety,...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Prats, Anthony J., Schaaf, H. Simon, Draper, Heather R., Garcia-Cremades, Maria, Winckler, Jana, Wiesner, Lubbe, Hesseling, Anneke C., Savic, Rada M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490911/
https://www.ncbi.nlm.nih.gov/pubmed/31039153
http://dx.doi.org/10.1371/journal.pmed.1002789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490911/
https://www.ncbi.nlm.nih.gov/pubmed/31039153
http://dx.doi.org/10.1371/journal.pmed.1002789

Ejemplares similares